A low GLP-1 response among patients treated for acute organophosphate and carbamate poisoning: a comparative cross-sectional study from an agrarian region of Sri Lanka.
Acetylcholinesterase
/ metabolism
Acute Disease
Adult
Atropine
/ therapeutic use
Carbamates
/ poisoning
Chronic Disease
Cross-Sectional Studies
Diabetes Mellitus, Type 2
/ epidemiology
Dose-Response Relationship, Drug
Erythrocytes
/ drug effects
Female
Glucagon-Like Peptide 1
/ metabolism
Humans
Incidence
Incretins
/ therapeutic use
Insecticides
/ poisoning
Male
Middle Aged
Occupational Exposure
/ adverse effects
Organophosphate Poisoning
/ complications
Sri Lanka
Acetylcholinesterase activity
Atropine
Carbamate
Diabetes mellitus
Glucagon-like peptide-1
Incretin effect
Organophosphate
Journal
Environmental science and pollution research international
ISSN: 1614-7499
Titre abrégé: Environ Sci Pollut Res Int
Pays: Germany
ID NLM: 9441769
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
26
04
2018
accepted:
21
11
2018
pubmed:
1
12
2018
medline:
23
2
2019
entrez:
1
12
2018
Statut:
ppublish
Résumé
Higher incidence of diabetes along with increased use of pesticides is seen in Southeast Asia. Recent hypothesis postulated a link between acetylcholinesterase inhibitor insecticides and type 2 diabetes through the GLP-1 pathway. This study compares the GLP-1 response between groups with low and high red blood cell acetylcholinesterase (RBC-AChE) activity. A comparative cross-sectional study was conducted amongst patients who were within 3 months after an acute organophosphate or carbamate poisoning (acute group) and amongst vegetable farmers with low (chronic group) and high (control group) RBC-AChE activity. Acute (366 mU/μM Hb) and chronic (361 mU/μM Hb) groups had significantly lower RBC-AChE activity in comparison to the control (471 mU/μM Hb) group (P < 0.0001). Only the acute group, which has had atropine therapy, showed a significantly lower 120 min value in comparison to the control group (P = 0.0028). Also, the acute group had significantly low late (P = 0.0287) and total (P = 0.0358) responses of GLP-1 in comparison to the control group. The findings of the study allude towards attenuation of GLP-1 response amongst patients after acute organophosphate and carbamate poisoning. The possibility of an atropine-mediated attenuation of GLP-1 response was discussed.
Identifiants
pubmed: 30499084
doi: 10.1007/s11356-018-3818-9
pii: 10.1007/s11356-018-3818-9
doi:
Substances chimiques
Carbamates
0
Incretins
0
Insecticides
0
Atropine
7C0697DR9I
Glucagon-Like Peptide 1
89750-14-1
Acetylcholinesterase
EC 3.1.1.7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2864-2872Subventions
Organisme : Research, Publication & Higher Degrees Committee, Rajarata University of Sri Lanka
ID : RJT/RP&HDC/2017/FMAS/R/01
Références
Toxicol Lett. 1998 Dec 28;102-103:649-52
pubmed: 10022329
Clin Chim Acta. 1999 Oct;288(1-2):73-90
pubmed: 10529460
Diabetes. 2001 Mar;50(3):609-13
pubmed: 11246881
Diabetes. 2001 May;50(5):1030-8
pubmed: 11334405
Endocrinology. 2002 Jun;143(6):2420-6
pubmed: 12021207
Pharmacol Biochem Behav. 2003 Mar;74(4):977-86
pubmed: 12667913
J Clin Endocrinol Metab. 1964 Oct;24:1076-82
pubmed: 14228531
Acta Clin Belg. 2003 Nov-Dec;58(6):335-41
pubmed: 15068125
Physiol Rev. 2007 Oct;87(4):1409-39
pubmed: 17928588
Am J Epidemiol. 2008 May 15;167(10):1235-46
pubmed: 18343878
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
JAMA. 2009 May 27;301(20):2129-40
pubmed: 19470990
Hum Exp Toxicol. 2011 Sep;30(9):1119-40
pubmed: 21071550
Diabetologia. 2011 Jun;54(6):1273-90
pubmed: 21442161
Environ Health Perspect. 1990 Jul;87:245-54
pubmed: 2176588
Environ Health Perspect. 2012 Jun;120(6):779-89
pubmed: 22296744
J Physiol. 2012 Jun 15;590(12):2917-36
pubmed: 22495587
BMC Public Health. 2012 Aug 02;12:593
pubmed: 22852867
Diabetologia. 2013 Apr;56(4):696-708
pubmed: 23344728
J Clin Endocrinol Metab. 2014 Jul;99(7):2457-66
pubmed: 24712563
Toxicology. 2014 Aug 1;322:1-13
pubmed: 24801903
J Diabetes Investig. 2010 Apr 22;1(1-2):8-23
pubmed: 24843404
Indian J Endocrinol Metab. 2015 Jan-Feb;19(1):30-8
pubmed: 25593823
J Diabetes Complications. 2015 Apr;29(3):445-50
pubmed: 25623632
Diabetes. 2015 Jul;64(7):2513-25
pubmed: 25677912
Lancet Diabetes Endocrinol. 2015 Dec;3(12):925-7
pubmed: 26575608
Med Hypotheses. 2016 Jun;91:53-55
pubmed: 27142144
BMC Health Serv Res. 2017 Jan 5;17(1):11
pubmed: 28056960
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
Diabetologia. 1986 Jan;29(1):46-52
pubmed: 3514343
J Clin Invest. 1967 Dec;46(12):1954-62
pubmed: 6074000
J Endocrinol. 1995 Oct;147(1):25-31
pubmed: 7490533
J Clin Endocrinol Metab. 1997 Mar;82(3):786-90
pubmed: 9062483